Magnetic resonance imaging

MegaPro MPB-1523, a MRI contrast agent for focal liver lesion, just completed its End of Phase 2 (EOP2) meeting with U.S. FDA and will aim to the IND of Phase III clinical trials.

Retrieved on: 
Wednesday, January 17, 2024

MegaPro MPB-1523, a MRI contrast agent for focal liver lesion, just completed its End of Phase 2 (EOP2) meeting with U.S. FDA and will aim to the IND of Phase III clinical trials.

Key Points: 
  • MegaPro MPB-1523, a MRI contrast agent for focal liver lesion, just completed its End of Phase 2 (EOP2) meeting with U.S. FDA and will aim to the IND of Phase III clinical trials.
  • Applications to the FDA for global phase III clinical trials are expected to take place in the second quarter of 2024.
  • Megapro states that the diagnosis of focal liver lesion by contrast-enhanced MRI remained an important clinical needs globally.
  • Therefore, MegaPro plans to further develop the MPB1523, nano-iron oxide MRI contrast agent, for its phase 3 study.

Longer-Term Nut Consumption Improves Brain Insulin Sensitivity, New Study Finds

Retrieved on: 
Tuesday, January 16, 2024

BARCELONA, Spain, Jan. 16, 2024 /PRNewswire/ -- Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity. This may be important for the prevention of age-related metabolic and cognitive diseases.

Key Points: 
  • The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity.
  • Cerebral blood flow (CBF) was quantified using magnetic resonance imaging (MRI), while brain insulin sensitivity was assessed by measuring regional CBF responses to intranasal insulin.
  • The study found that nut consumption significantly improved insulin action in (occipital and frontal) brain regions involved in the modulation of metabolic and cognitive processes.
  • However, intrahepatic lipid content, serum LDL ('bad') cholesterol and systolic blood pressure were lower following nut consumption compared to the control period.

Longer-Term Nut Consumption Improves Brain Insulin Sensitivity, New Study Finds

Retrieved on: 
Tuesday, January 16, 2024

BARCELONA, Spain, Jan. 16, 2024 /PRNewswire/ -- Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity. This may be important for the prevention of age-related metabolic and cognitive diseases.

Key Points: 
  • The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity.
  • Cerebral blood flow (CBF) was quantified using magnetic resonance imaging (MRI), while brain insulin sensitivity was assessed by measuring regional CBF responses to intranasal insulin.
  • The study found that nut consumption significantly improved insulin action in (occipital and frontal) brain regions involved in the modulation of metabolic and cognitive processes.
  • However, intrahepatic lipid content, serum LDL ('bad') cholesterol and systolic blood pressure were lower following nut consumption compared to the control period.

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

Retrieved on: 
Tuesday, January 9, 2024

WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023.
  • The fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% from the prior year.
  • “We are very pleased to announce these fourth quarter 2023 preliminary results, which is our highest quarterly revenue ever and continues our string of ten consecutive quarters of record revenues.
  • The value of our products continues to resonate with our customers as we see growing demand for our products and expect this to continue through 2024,” said Roger Susi, President and Chief Executive Officer of the Company.

Introduction of Breast Imaging Legislation Will Benefit Thousands of Pennsylvanians

Retrieved on: 
Friday, January 12, 2024

HARRISBURG, Pa., Jan. 12, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization commends Representative Curry (D-Delaware County) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • In Pennsylvania, more than 12,830 people were diagnosed with breast cancer and more than 1870 died of the disease in 2023 alone.
  • House Bill 1944 , introduced by Representative Curry, eliminates the patient out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging including MRIs, ultrasounds, and diagnostic mammograms.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.

Broward County (FL) High School Students get Insider's View, Perspective on Careers in Healthcare

Retrieved on: 
Friday, January 12, 2024

HOLLYWOOD, Fla., Jan. 12, 2024 /PRNewswire-PRWeb/ -- Nearly 100 young men from five Broward County high schools were recently introduced to the many careers and opportunities that exist in the healthcare industry. The students, most of them from underrepresented communities, participated in hands-on demonstrations at Memorial Regional and Joe DiMaggio Children's hospitals and heard from Memorial Healthcare System physicians and administrators that came from backgrounds similar to theirs.

Key Points: 
  • Local high school students in the 5,000 Role Models of Excellence program saw and heard about potential post-graduation opportunities in the healthcare field.
  • HOLLYWOOD, Fla., Jan. 12, 2024 /PRNewswire-PRWeb/ -- Nearly 100 young men from five Broward County high schools were recently introduced to the many careers and opportunities that exist in the healthcare industry.
  • Students from Hollywood Hills, Charles W. Flanagan, Boyd H. Anderson, Nova, and Hallandale high schools attended.
  • Students are also exposed to valuable educational and leadership opportunities that are designed to develop and strengthen their leadership skills.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

Neural Propulsion Systems (NPS) Showcases Unparalleled Sensor Safety Performance at CES 2024

Retrieved on: 
Wednesday, January 10, 2024

LAS VEGAS and PLEASANTON, Calif., Jan. 10, 2024 /PRNewswire/ -- Neural Propulsion Systems (NPS), a software platform company offering ultra-resolution imaging radar to support automotive vision sensing, used CES 2024 to showcase a demonstration of the ability to detect pedestrians and complex traffic situations with industry-leading clarity.

Key Points: 
  • Our technology is akin to improving automotive imaging from 20/20 vision to better than 20/10 vision."
  • The CES presentation shows the performance of an automotive radar system based on latest available Texas Instruments 77 GHz chipsets in A versus B testing with and without NPS technology.
  • It also significantly increases reliability by reducing the false positives that plague conventional automotive radar by over ten times.
  • "Chipmakers could use NPS to achieve ultra-resolution performance in real time, more than nine times beyond current systems," said Rezvani.

Introduction of Breast Imaging Legislation Will Benefit Thousands of New Hampshire Residents

Retrieved on: 
Tuesday, January 9, 2024

CONCORD, N.H., Jan. 9, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, commends Representative Catherine Rombeau (D-Bedford) for working with Komen to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging.

Key Points: 
  • In New Hampshire, nearly 1,400 people were diagnosed with breast cancer and 180 died of the disease in 2023 alone.
  • "We know that early detection of breast cancer saves lives, yet too many patients in New Hampshire are forced to put off diagnostic imaging due to cost concerns.
  • An estimated 12% of individuals are called back for additional imaging after an abnormal screening mammogram and require diagnostic imaging.
  • This diagnostic or supplemental imaging is often crucial for individuals previously diagnosed with breast cancer or those considered high-risk.